中商官网
研究报告
易明医药（002826）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 221000000.0000 | 14237900.0000 | 26194600.0000 | 21823200.0000 | 153000000.0000 | 81432600.0000 | 71664800.0000 |
| 2014 | 291000000.0000 | 29965100.0000 | 42534400.0000 | 33856800.0000 | 268000000.0000 | 89296300.0000 | 179000000.0000 |
| 2015 | 347000000.0000 | 45458100.0000 | 56119100.0000 | 50029900.0000 | 398000000.0000 | 149000000.0000 | 248000000.0000 |
| 2016 | 452000000.0000 | 47151100.0000 | 63197000.0000 | 55358500.0000 | 646000000.0000 | 90925300.0000 | 555000000.0000 |
| 2017 | 380000000.0000 | 65101100.0000 | 67917100.0000 | 60476600.0000 | 733000000.0000 | 129000000.0000 | 605000000.0000 |
| 2018 | 489000000.0000 | 26856500.0000 | 28993000.0000 | 25255000.0000 | 758000000.0000 | 140000000.0000 | 618000000.0000 |
| 2019 | 553000000.0000 | 47703700.0000 | 47737300.0000 | 37329000.0000 | 835000000.0000 | 183000000.0000 | 652000000.0000 |
| 2020 | 603000000.0000 | 43126400.0000 | 47348400.0000 | 41091200.0000 | 908000000.0000 | 221000000.0000 | 687000000.0000 |
| 2021 | 725000000.0000 | 48636800.0000 | 50012900.0000 | 43473300.0000 | 824000000.0000 | 104000000.0000 | 720000000.0000 |
| 2022 | 857000000.0000 | 55729400.0000 | 56702600.0000 | 46115900.0000 | 1018000000.0000 | 268000000.0000 | 750000000.0000 |
| 2023 | 667000000.0000 | 23504900.0000 | 23599500.0000 | 15725600.0000 | 928000000.0000 | 178000000.0000 | 750000000.0000 |
| 2024 | 652000000.0000 | 61501200.0000 | 60375600.0000 | 47460000.0000 | 926000000.0000 | 181000000.0000 | 746000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 6.33 | 11.85 | 17.12 | 35.7200 | 3.2700 | 48.65 | 1.44 |
| 2014 | 10.31 | 14.62 | 15.87 | 26.5200 | 3.5300 | 19.85 | 1.09 |
| 2015 | 12.97 | 16.17 | 14.10 | 24.5100 | 2.8000 | 9.22 | 0.87 |
| 2016 | 10.40 | 13.98 | 9.78 | 18.6400 | 3.1600 | 6.98 | 0.70 |
| 2017 | 11.05 | 17.87 | 9.27 | 10.4600 | 3.0700 | 4.75 | 0.52 |
| 2018 | -0.41 | 5.93 | 3.82 | 4.1400 | 10.5900 | 5.97 | 0.65 |
| 2019 | 3.62 | 8.63 | 5.72 | 5.8800 | 12.7300 | 7.33 | 0.66 |
| 2020 | 3.65 | 7.85 | 5.21 | 6.1400 | 15.3400 | 9.54 | 0.66 |
| 2021 | 3.45 | 6.90 | 6.07 | 6.0600 | 17.1200 | 15.35 | 0.88 |
| 2022 | 3.62 | 6.62 | 5.57 | 6.0400 | 12.1400 | 8.60 | 0.84 |
| 2023 | 1.20 | 3.54 | 2.54 | 2.0700 | 6.2300 | 6.96 | 0.72 |
| 2024 | 4.29 | 9.26 | 6.52 | 6.2600 | 4.1000 | 18.99 | 0.70 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 53.22 | 46.84 | 0.9600 | 0.5200 |
| 2014 | 33.32 | 66.79 | 1.7900 | 0.9400 |
| 2015 | 37.44 | 62.31 | 1.9400 | 1.0600 |
| 2016 | 14.08 | 85.91 | 5.0800 | 4.4300 |
| 2017 | 17.60 | 82.54 | 3.8000 | 3.4400 |
| 2018 | 18.47 | 81.53 | 3.3700 | 3.1000 |
| 2019 | 21.92 | 78.08 | 2.2200 | 1.9900 |
| 2020 | 24.34 | 75.66 | 2.0600 | 1.9400 |
| 2021 | 12.62 | 87.38 | 3.6500 | 3.2200 |
| 2022 | 26.33 | 73.67 | 2.2000 | 2.0000 |
| 2023 | 19.18 | 80.82 | 2.8600 | 2.5100 |
| 2024 | 19.55 | 80.56 | 3.0100 | 2.7600 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 207000000.0000 | 82622500.0000 | 32667700.0000 | 2957900.0000 |
| 2014 | 261000000.0000 | 123000000.0000 | 28581100.0000 | 1472600.0000 |
| 2015 | 302000000.0000 | 156000000.0000 | 31876900.0000 | 1146900.0000 |
| 2016 | 405000000.0000 | 215000000.0000 | 40179100.0000 | 4904700.0000 |
| 2017 | 338000000.0000 | 182000000.0000 | 32312100.0000 | 551300.0000 |
| 2018 | 491000000.0000 | 98958400.0000 | 32975000.0000 | 1379800.0000 |
| 2019 | 533000000.0000 | 111000000.0000 | 36514700.0000 | 2708400.0000 |
| 2020 | 581000000.0000 | 143000000.0000 | 35371500.0000 | 1617300.0000 |
| 2021 | 700000000.0000 | 173000000.0000 | 45910500.0000 | 843100.0000 |
| 2022 | 826000000.0000 | 271000000.0000 | 47245300.0000 | 821600.0000 |
| 2023 | 659000000.0000 | 247000000.0000 | 51010800.0000 | 1172200.0000 |
| 2024 | 624000000.0000 | 341000000.0000 | 49417500.0000 | 445900.0000 |